Cornerstone Financial Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cornerstone Financial Management's BIIB Position: Q2 2026 in Review
Cornerstone Financial Management increased its Biogen (BIIB) stake by 71% in Q2 2026, buying an estimated $6.5K and bringing the position to 82 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #304.
Cornerstone Financial Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Cornerstone Financial Management held 82 shares of Biogen worth $17.7K as of Q2 2026.
- Cornerstone Financial Management bought 34 Biogen shares in Q2 2026, an estimated $6.5K.
- Biogen made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #304 holding.
- Cornerstone Financial Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.